Jason L. DeHart

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Vaccines based on mutant CALR and JAK2 and their uses
- Patent number 12,018,289
- Issue date Jun 25, 2024
- Janssen Biotech, Inc.
- Ricardo Attar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for enhancing gene expression
- Patent number 11,845,939
- Issue date Dec 19, 2023
- Janssen Pharmaceuticals, Inc.
- Kurt Iver Kamrud
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Induce and enhance immune responses using recombinant replicon systems
- Patent number 11,826,416
- Issue date Nov 28, 2023
- Janssen Pharmaceuticals, Inc.
- Kurt Iver Kamrud
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Induce and enhance immune responses using recombinant replicon systems
- Patent number 11,083,786
- Issue date Aug 10, 2021
- Janssen Pharmaceuticals, Inc.
- Kurt Iver Kamrud
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HSV-1 oncolytic virus therapies that specifically kill ALT dependen...
- Patent number 10,821,141
- Issue date Nov 3, 2020
- Salk Institute for Biological Studies
- Clodagh O'Shea
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
- Publication number 20240294884
- Publication date Sep 5, 2024
- JANSSEN BIOTECH, INC.
- Ricardo ATTAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION
- Publication number 20240209379
- Publication date Jun 27, 2024
- JANSSEN PHARMACEUTICALS, INC
- Kurt Iver KAMRUD
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS
- Publication number 20240042005
- Publication date Feb 8, 2024
- JANSSEN PHARMACEUTICALS, INC
- Kurt Iver KAMRUD
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Prostate Neoantigens And Their Uses
- Publication number 20230029453
- Publication date Feb 2, 2023
- JANSSEN BIOTECH, INC.
- Jason Lee DeHart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prostate Neoantigens And Their Uses
- Publication number 20230024133
- Publication date Jan 26, 2023
- JANSSEN BIOTECH, INC.
- Jason Lee DeHart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA REPLICON VACCINES AGAINST HBV
- Publication number 20220016237
- Publication date Jan 20, 2022
- Jason L. DEHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SARS-CoV-2 Vaccines
- Publication number 20210346492
- Publication date Nov 11, 2021
- JANSSEN PHARMACEUTICALS, INC
- Jason DEHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA Replicon Encoding a Stabilized Corona Virus Spike Protein
- Publication number 20210347828
- Publication date Nov 11, 2021
- JANSSEN PHARMACEUTICALS, INC
- Jason DEHART
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS
- Publication number 20210330781
- Publication date Oct 28, 2021
- JANSSEN PHARMACEUTICALS, INC
- Kurt Iver KAMRUD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
- Publication number 20210222133
- Publication date Jul 22, 2021
- JANSSEN BIOTECH, INC.
- Ricardo ATTAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDEN...
- Publication number 20210220417
- Publication date Jul 22, 2021
- Salk Institute for Biological Studies
- Clodagh O'Shea
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHAVIRUS-BASED REPLICONS FOR ADMINISTRATION OF BIOTHERAPEUTICS
- Publication number 20200109178
- Publication date Apr 9, 2020
- JANSSEN PHARMACEUTICALS, INC
- Jason L. DEHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS
- Publication number 20190224299
- Publication date Jul 25, 2019
- Synthetic Genomics, Inc.
- Kurt Iver Kamrud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDEN...
- Publication number 20190046594
- Publication date Feb 14, 2019
- Salk Institute for Biological Studies
- Clodagh O'Shea
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION
- Publication number 20180171340
- Publication date Jun 21, 2018
- Synthetic Genomics, Inc.
- Kurt Iver Kamrud
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jason L. DeHart

Person

Patents Grantslast 30 patents

Vaccines based on mutant CALR and JAK2 and their uses

Compositions and methods for enhancing gene expression

Induce and enhance immune responses using recombinant replicon systems

Induce and enhance immune responses using recombinant replicon systems

HSV-1 oncolytic virus therapies that specifically kill ALT dependen...

Patents Applicationslast 30 patents

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION

INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS

Prostate Neoantigens And Their Uses

Prostate Neoantigens And Their Uses

RNA REPLICON VACCINES AGAINST HBV

SARS-CoV-2 Vaccines

RNA Replicon Encoding a Stabilized Corona Virus Spike Protein

INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDEN...

ALPHAVIRUS-BASED REPLICONS FOR ADMINISTRATION OF BIOTHERAPEUTICS

INDUCE AND ENHANCE IMMUNE RESPONSES USING RECOMBINANT REPLICON SYSTEMS

HSV-1 ONCOLYTIC VIRUS THERAPIES THAT SPECIFICALLY KILL ALT DEPENDEN...

COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION